The Safety and Efficacy of KSVCBD Injection in Neuromyelitis Optica Spectrum Disorder.

Clinical trial NCT07592754 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07592754
Sponsor: Chinese PLA General Hospital
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Neuromyelitis Optica Spectrum Disease (NMOSD)

Start date: 2026-05-15
Primary completion: 2028-12-31
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.